Michael Graupe

This inventor holds 76 USPTO granted patents and 18 published patent applications, plus 16 CIPO patents and 40 EPO patents, primarily in Therapeutic Compounds (CPC class C07D). Top assignees: Gilead Sciences, Inc., Virobay, Inc., Axys Pharmaceuticals, Inc.. Active years: 2002-2026.

USPTO Granted Patents = 76 (Patent Applications = 18)

% Patents Active = 85.5

CIPO Patents = 16 (Patent Applications = 13)

EPO Patents = 40 (Patent Applications = 57)

Average Co-Inventor Count = 5.5

ph-index = 12

Forward Citations = 507(Granted Patents)

Forward Citations (Not Self Cited) = 373(Dec 10, 2025)

Inventors with similar research interests:

Location History:

San Mateo, CA (US) (2002 - 2003)
Foster City, CA (US) (2012 - 2023)
Pacifica, CA (US) (2006 - 2024)

Company Filing History:

56 out of 946

Gilead Sciences, Inc.

Axys Pharmaceuticals, Inc.

patents

4. 4 out of 81

Gilead Pharmasset LLC

patents

5. 3 out of 207

Aventis Pharmaceuticals Inc.

patents

6. 2 out of 5

Amygdala Neurosciences, Inc.

patents

7. 1 out of 1

Gilead Scineces, Inc.

patent

8. 1 out of 1,409

Schering Aktiengesellschaft

patents

9. 1 out of 618

University of Houston System

patents

where one patent can have more than one assignee

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

PD-1 Inhibitors

GLP-1R Modulators

Therapeutic Compounds

HIV Treatment

Diacylglycerol Kinase

Ion Channel Modulators

Addiction Treatment

Apoptosis Regulators

Antiviral Compounds

Toll-Like Receptor Modulators

Fused Heterocyclic Compounds

76 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12590062 - PD-1/PD-L1 inhibitors (2026-03-31),

2. 12497382 - GLP-1R modulating compounds (2025-12-16),

3. 12404262 - Therapeutic compounds for HIV virus infection (2025-09-02),

4. 12338233 - PD-1/Pd-L1 inhibitors (2025-06-24),

5. 12269812 - PD-1/PD-L1 inhibitors (2025-04-08),

6. 11993583 - Therapeutic compounds (2024-05-28),

7. 11976072 - Diacylglycerol kinase modulating compounds (2024-05-07),

8. 11932634 - Diacylglycerol kinase modulating compounds (2024-03-19),

9. 11926628 - Diacylglyercol kinase modulating compounds (2024-03-12),

10. 11845723 - Diacylglycerol kinase modulating compounds (2023-12-19),

11. 11753399 - Therapeutic compounds (2023-09-12),

12. 11702404 - GLP-1R modulating compounds (2023-07-18),

13. 11555029 - PD-1/PD-L1 inhibitors (2023-01-17),

14. 11267801 - Therapeutic compounds (2022-03-08),

15. 11236085 - PD-1/PD-L1 inhibitors (2022-02-01),

Title: The Inventor Michael Graupe: Pioneering Innovations in Pacifica, CA

Introduction: Michael Graupe is a renowned inventor based in Pacifica, CA, known for his groundbreaking contributions to various industries.

Latest Patents: Michael Graupe holds several patents in the fields of technology and engineering, with his most recent inventions focusing on sustainable energy solutions and advanced robotics.

Career Highlights: With a career spanning over two decades, Michael Graupe has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized the way we live and work.

Collaborations: Throughout his career, Michael Graupe has collaborated with top engineers, scientists, and inventors to bring his ideas to life, resulting in successful partnerships that have led to the creation of innovative products and solutions.

Conclusion: Michael Graupe's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and inspiring the next generation of inventors.